Compared to Estimates, Celanese (CE) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2025, Celanese (CE) reported revenue of $2.53 billion, down 4.5% over the same period last year. EPS came in at $1.44, compared to $2.38 in the year-ago quarter.The reported revenue represents a surprise of +1.42% over the Zacks Consensus Estimate of $2.5 billion. With the consensus EPS estimate being $1.38, the EPS surprise was +4.35%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Celanese performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales- Acetyl Chain: $1.12 billion versus the four-analyst average estimate of $1.1 billion. The reported number represents a year-over-year change of -7.2%.Net Sales- Inter segment eliminations: $-25 million versus $-20.32 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +38.9% change.Net Sales- Engineered Materials: $1.44 billion versus the four-analyst average estimate of $1.35 billion. The reported number represents a year-over-year change of -1.7%.Operating EBITDA- Acetyl Chain: $260 million compared to the $287.13 million average estimate based on four analysts.Operating EBITDA- Other Activities: $-54 million compared to the $-56.51 million average estimate based on four analysts.Operating EBITDA- Engineered Materials: $326 million compared to the $278.5 million average estimate based on four analysts.View all Key Company Metrics for Celanese here>>>Shares of Celanese have returned -21.3% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Celanese Corporation (CE): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks